Health Condition 1: C760- Malignant neoplasm of head, face and neck Health Condition 2: C00-C14- Malignant neoplasms of lip, oral cavity and pharynx
Conditions
Interventions
Intervention1: Experimental group (Arm A): Participants of this arm will be given 22.5-
gram equivalent to 15.75 millilitres [@ 0.45gm/kg body weight: an
average body weight of 50 kilogram] of same br
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: 1 Patients with head and neck cancer undergoing neo-adjuvant chemotherapy 2 Age greater than 18 years 3 Patients who are willing to participate in the study and one fit for DCF or DC The Objective criteria as fit for DCF or DC will be as follows A ECOG Performance scale 02 B Normal organ function test values a Creatinine clearance greater than equal to 30ml per min b SGPT or SGOT less than equal to 3.5ULN c Hemoglobin greater than 8 gm d ANC equal to 1000 e Platelet equal to 1 lakh
Exclusion criteria
Exclusion criteria: 1 Patients with any other site solid tumor. 2 Patients with hematolymphoid cancer. 3 All patients with diabetic mellitus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?? To assess the efficacy of honey in reducing chemotherapy induced grade 3 or worse febrile neutropenia.Timepoint: 34 DAYS | — |
Secondary
| Measure | Time frame |
|---|---|
| â?? Clinical data would be analysed to Grade anemia, thrombocytopenia and neutropenia. â?? Incidence of febrile neutropenia would be reported in counts and percentages. â?? The factors including duration of hospitalization and number of episodes of hospitalization) influenced by febrile neutropenia would be analyzedTimepoint: 34 DYAS | — |
Countries
India
Contacts
Public ContactMr Sameer Sanjay
TATA MEMORIAL HOSPITAL
Outcome results
None listed